BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bailly C. The implication of the PD-1/PD-L1 checkpoint in chronic periodontitis suggests novel therapeutic opportunities with natural products. Jpn Dent Sci Rev 2020;56:90-6. [PMID: 32612718 DOI: 10.1016/j.jdsr.2020.04.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Ning W, Acharya A, Sun Z, Ogbuehi AC, Li C, Hua S, Ou Q, Zeng M, Liu X, Deng Y, Haak R, Ziebolz D, Schmalz G, Pelekos G, Wang Y, Hu X. Deep Learning Reveals Key Immunosuppression Genes and Distinct Immunotypes in Periodontitis. Front Genet 2021;12:648329. [PMID: 33777111 DOI: 10.3389/fgene.2021.648329] [Reference Citation Analysis]
2 Suárez LJ, Garzón H, Arboleda S, Rodríguez A. Oral Dysbiosis and Autoimmunity: From Local Periodontal Responses to an Imbalanced Systemic Immunity. A Review. Front Immunol 2020;11:591255. [PMID: 33363538 DOI: 10.3389/fimmu.2020.591255] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
3 Ri MH, Ma J, Jin X. Development of natural products for anti-PD-1/PD-L1 immunotherapy against cancer. J Ethnopharmacol 2021;281:114370. [PMID: 34214644 DOI: 10.1016/j.jep.2021.114370] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Patil S, Sayed ME, Mugri MH, Alsharif KF, Salman A, Bhandi S, Baeshen HA, Balaji TM, Yadalam PK, Varadarajan S, Radha RSR, Awan KH, Patil VR, Raj AT. Allicin May Promote Reversal of T-Cell Dysfunction in Periodontitis via the PD-1 Pathway. Int J Mol Sci 2021;22:9162. [PMID: 34502071 DOI: 10.3390/ijms22179162] [Reference Citation Analysis]
5 Wongtim K, Ikeda E, Ohno T, Nagai S, Okuhara S, Kure K, Azuma M. Overexpression of PD-L1 in gingival basal keratinocytes reduces periodontal inflammation in a ligature-induced periodontitis model. J Periodontol 2021. [PMID: 34021604 DOI: 10.1002/JPER.21-0017] [Reference Citation Analysis]
6 Zhao C, Zou T, Tang R, Zhu C. Placenta-specific 8 (PLAC8) mediates inflammation and mobility of the hPDLCs via MEK/ERK signaling pathway. Int Immunopharmacol 2021;103:108459. [PMID: 34954560 DOI: 10.1016/j.intimp.2021.108459] [Reference Citation Analysis]